Actinium Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $35,000 | $0 | $0 | $90 |
Gross Profit | 35,000 | -220 | 615 | 90 |
EBITDA | 28,142 | -5,302 | -5,734 | -4,925 |
EBIT | 27,901 | -5,522 | -5,940 | -5,131 |
Net Income | 27,901 | -5,522 | -5,940 | -5,131 |
Net Change In Cash | 35,000 | 0 | 0 | 90 |
Free Cash Flow | -5,657 | -5,872 | -5,393 | -6,325 |
Cash | 36,473 | 42,132 | 47,998 | 53,391 |
Basic Shares | 31,406 | 31,237 | 31,195 | 31,195 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $90 | $0 | $81 | $1,030 |
Gross Profit | 90 | -811 | 81 | 1,030 |
EBITDA | -33,066 | -37,432 | -48,028 | -32,318 |
EBIT | -33,887 | -38,243 | -48,818 | -33,017 |
Net Income | -33,887 | -38,243 | -48,818 | -33,017 |
Net Change In Cash | 90 | 0 | 81 | 1,030 |
Free Cash Flow | -24,684 | -33,083 | -47,488 | 8,278 |
Cash | 47,998 | 72,904 | 76,677 | 108,910 |
Basic Shares | 31,195 | 30,070 | 26,604 | 24,142 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.89 |
2026-03-31 | -$0.18 |
2025-12-31 | -$0.19 |
2025-09-30 | -$0.16 |